One of the main regulators of lnc-DHX32-2:1, which targeted for gene ADAM12, has been implicated in a variety of biological processes, including lung cancer and the development of giant cell tumors, and positively involved in the regulation of the MAPK/ERK pathway. The gene discussed is ADAM12; the disease is lung carcinoma.